ZBTB46 coordinates angiogenesis and immunity to control tumor outcome

Subramanian, M., Kabir, A. U., Barisas, D., Krchma, K. & Choi, K. Conserved angio-immune subtypes of the tumor microenvironment predict response to immune checkpoint blockade therapy. Cell Rep. Med. 4, 100896 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Satpathy, A. T. et al. Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J. Exp. Med. 209, 1135–1152 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meredith, M. M. et al. Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J. Exp. Med. 209, 1153–1165 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu, C., Hua, Q. & Zheng, L. Generation of myeloid cells in cancer: the spleen matters. Front. Immunol. 11, 1126 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31–46 (2022).

Article  CAS  PubMed  Google Scholar 

Salmon, H., Remark, R., Gnjatic, S. & Merad, M. Host tissue determinants of tumour immunity. Nat. Rev. Cancer 19, 215–227 (2019).

CAS  PubMed  PubMed Central  Google Scholar 

Bejarano, L., Jordao, M. J. C. & Joyce, J. A. Therapeutic targeting of the tumor microenvironment. Cancer Discov. 11, 933–959 (2021).

Article  CAS  PubMed  Google Scholar 

Ribas, A. & Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science 359, 1350–1355 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Waldman, A. D., Fritz, J. M. & Lenardo, M. J. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat. Rev. Immunol. 20, 651–668 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jain, R. K. Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. Cancer Cell 26, 605–622 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schaum, N. et al. Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris: The Tabula Muris Consortium. Nature 562, 367–372 (2018).

Article  PubMed Central  Google Scholar 

Meredith, M. M. et al. Zinc finger transcription factor zDC is a negative regulator required to prevent activation of classical dendritic cells in the steady state. J. Exp. Med. 209, 1583–1593 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, Y. et al. ZBTB46 is a shear-sensitive transcription factor inhibiting endothelial cell proliferation via gene expression regulation of cell cycle proteins. Lab. Invest. 99, 305–318 (2019).

Article  CAS  PubMed  Google Scholar 

Martin, J. D., Seano, G. & Jain, R. K. Normalizing function of tumor vessels: progress, opportunities, and challenges. Annu. Rev. Physiol. 81, 505–534 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schmittnaegel, M. et al. Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade. Sci. Transl. Med. 9, aak9670 (2017).

Article  Google Scholar 

Kabir, A. U. et al. Dual role of endothelial Myct1 in tumor angiogenesis and tumor immunity. Sci. Transl. Med. 13, eabb6731 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hildner, K. et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322, 1097–1100 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Devalaraja, S. et al. Tumor-derived retinoic acid regulates intratumoral monocyte differentiation to promote immune suppression. Cell 180, 1098–1114 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hirai, H. et al. C/EBPbeta is required for ‘emergency’ granulopoiesis. Nat. Immunol. 7, 732–739 (2006).

Article  CAS  PubMed  Google Scholar 

Huber, R., Pietsch, D., Panterodt, T. & Brand, K. Regulation of C/EBPβ and resulting functions in cells of the monocytic lineage. Cell Signal. 24, 1287–1296 (2012).

Article  CAS  PubMed  Google Scholar 

Cohen, D. M., Lim, H. W., Won, K. J. & Steger, D. J. Shared nucleotide flanks confer transcriptional competency to bZip core motifs. Nucleic Acids Res. 46, 8371–8384 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moreno Ayala, M. A. et al. CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+ T cell antitumor immunity. Immunity 56, 1613–1630 (2023).

Article  CAS  PubMed  Google Scholar 

Xing, S. et al. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. J. Exp. Med. 216, 847–866 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dalod, M., Chelbi, R., Malissen, B. & Lawrence, T. Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming. EMBO J. 33, 1104–1116 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen, P. et al. Circadian regulator CLOCK recruits immune-suppressive microglia into the GBM tumor microenvironment. Cancer Discov. 10, 371–381 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kabir, A. U. et al. Requisite endothelial reactivation and effective siRNA nanoparticle targeting of Etv2/Er71 in tumor angiogenesis. JCI Insight 3, e97349 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Yan, H. et al. Induction of WNT16 via peptide-mRNA nanoparticle-based delivery maintains cartilage homeostasis. Pharmaceutics https://doi.org/10.3390/pharmaceutics12010073 (2020).

Pandey, V. K., Amin, P. J. & Shankar, B. S. COX-2 inhibitor prevents tumor induced down regulation of classical DC lineage specific transcription factor Zbtb46 resulting in immunocompetent DC and decreased tumor burden. Immunol. Lett. 184, 23–33 (2017).

Article  CAS  PubMed  Google Scholar 

Zhou, W. et al. ZBTB46 defines and regulates ILC3s that protect the intestine. Nature 609, 159–165 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choi, Y. & Jung, K. Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy. Exp. Mol. Med. 55, 2308–2319 (2023).

Article  CAS  PubMed  PubMed Central 

Comments (0)

No login
gif